A delicate balancing act

被引:0
|
作者
不详
机构
关键词
D O I
10.1038/nrd2413
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Timely access to novel therapies for life-threatening diseases is in the spotlight in the wake of a US court ruling that patients do not have a constitutional right to investigational drugs. How might the desire for early access to therapies and the need to demonstrate efficacy and safety be more effectively balanced?
引用
收藏
页码:685 / 685
页数:1
相关论文
共 50 条